Oncternal Therapeutics (ONCT) Q3 2024 Earnings

6NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q3 2024
-3.19
-3.07
-2.95
-2.83

Details

Expected EPS
-3.19
Actual EPS
-2.86
Surprise EPS
0.33
Surprise Percent
+10.34%

Description

Oncternal Therapeutics (ONCT) has reported earnings of -2.86 per share for Q3 2024.

0 Comments

Share your thoughts